AR09365PU-N Cytokeratin 20

Search for all "Cytokeratin 20"

0.25 mg / €520.00
Please visit the country specific website of OriGene Technologies or contact your local Distributor to buy this product.

Quick Overview

Cytokeratin 20

AR09365PU-N

Product Description for Cytokeratin 20

Cytokeratin 20.
Presentation: Purified

Properties for Cytokeratin 20

Product Category Proteins & Growth Factors
Quantity 0.25 mg
Synonyms CK20, Cytokeratin 20, K20, KRT20, Keratin type I cytoskeletal 20, Keratin-20, Protein IT
Presentation Purified
Molecular weight 46 kDa
Source E. coli
Species (Protein) Human
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer OriGene Technologies GmbH
Material safety datasheet MSDS for Proteins (de)

Datasheet Extract

Immunogen
Swiss Prot Num:
P35900
Purity > 95 % determined by SDS gelelectrophoresis
Add. information Isoelectric Point pI 5.66
Application Protein standard in 1D and 2D SDS gelelectrophoresis.
Immunoassays.
Immunization.
Background Cytokeratin 20 is a type I keratin which is primarily expressed in gastric and intestinal epithelium, urothelium, and Merkel-cells. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Their genes are clustered in a region of chromosome 17q12-q21. Cytokeratin 20 is a major cellular protein of mature enterocytes and goblet cells and is specifically expressed in the gastric and intestinal mucosa. It is also expressed in adenocarcinomas of the colon, stomach, pancreas and the bile system and is present in mucinous ovarian tumors, transitional-cell and Merkel-cell carcinomas. Notably, the squamous cell carcinomas and adenocarcinomas of the breast, lung, and endometrium, non-mucinous tumors of the ovary, and small cell carcinomas lack cytokeratin 20.
Concentration 1,0 mg/ml
Protocols Reconstitution to filaments is performed by mixing equimolar amounts of keratins of type I and type II at concentrations of approx. 0.5 mg/ml, both dissolved in 9.5 M urea buffer (see above). Protofilaments and filament complexes are obtained by dialyzing the resulting polypeptide solution stepwise to a concentration of 4 M urea and then to low salt condition (50 mM NaCl, 2 mM dithiothreitol, 10 mM Tris-HCl, pH 7.4). For immunization purposes, the solution can be further dialyzed against PBS (phosphate buffered saline, e.g. Dulbecco's PBS).
General Readings
  1. Moll et al (1990). J Cell Biol 111, 576-580
  2. Moll et al (1993). Differentiation 53, 75-93
  3. Hofmann I, Franke WW. Heterotypic interactions and filament assembly of type I and type II cytokeratins in vitro: viscometry and determinations of relative affinities. Eur J Cell Biol. 1997 Feb;72(2):122-32. PubMed PMID: 9157008.
Storage Prior to reconstitution store at 2-8°C.
Following reconstitution store the antibody at -20°C.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Description
Description:
Recombinant human keratin K20 (formerly also designated cytokeratin 20).
Format
Buffer System:
30 mM Tris/HCI pH 8, 9.5 M urea, 2 mM DTT, 2 mM EDTA, 10 mM methylammonium chloride
Purity:
>95% determined by SDS gelelectrophoresis
State:
Lyophilised purified protein
Purified
Reconstitution:
Reconstitute with 175 µl distilled water (final volume 250 µl)
Reconstitute with 70 µl distilled water (final volume 100 µl)
  • LinkedIn